Found: 22
Select item for more details and to access through your institution.
Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 647, doi. 10.1002/cpdd.663
- By:
- Publication type:
- Article
Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 5, p. 657, doi. 10.1002/cpdd.662
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Administration of Verinurad and Febuxostat in Healthy Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 2, p. 179, doi. 10.1002/cpdd.463
- By:
- Publication type:
- Article
Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 4, p. 377, doi. 10.1002/cpdd.323
- By:
- Publication type:
- Article
Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 4, p. 363, doi. 10.1002/cpdd.324
- By:
- Publication type:
- Article
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1107-x
- By:
- Publication type:
- Article
Predictive Models of Diffusive Nanoparticle Transport in 3-Dimensional Tumor Cell Spheroids.
- Published in:
- AAPS Journal, 2013, v. 15, n. 3, p. 816, doi. 10.1208/s12248-013-9478-2
- By:
- Publication type:
- Article
Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
- Published in:
- Rheumatology, 2018, v. 57, n. 9, p. 1602, doi. 10.1093/rheumatology/key100
- By:
- Publication type:
- Article
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
- Published in:
- Rheumatology, 2014, v. 53, n. 12, p. 2167, doi. 10.1093/rheumatology/ket487
- By:
- Publication type:
- Article
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 8, p. 703, doi. 10.1007/s40261-018-0652-2
- By:
- Publication type:
- Article
In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 6, p. 443, doi. 10.1007/s40261-016-0386-y
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 1799, doi. 10.2147/DDDT.S152659
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 2077, doi. 10.2147/DDDT.S140658
- By:
- Publication type:
- Article
Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
- Published in:
- Drug Design, Development & Therapy, 2016, v. 10, p. 3555, doi. 10.2147/DDDT.S119944
- By:
- Publication type:
- Article
Supratherapeutic dose evaluation and effect of lesinurad on cardiac repolarization: a thorough QT/QTc study.
- Published in:
- Drug Design, Development & Therapy, 2016, v. 10, p. 3509, doi. 10.2147/DDDT.S114455
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 3423, doi. 10.2147/DDDT.S85193
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.
- Published in:
- Drug Design, Development & Therapy, 2015, v. 9, p. 3423, doi. 10.2147/DDDT.S85193
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With Gout.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 9, p. 1214, doi. 10.1002/jcph.1119
- By:
- Publication type:
- Article
The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 9, p. 1164, doi. 10.1002/jcph.1124
- By:
- Publication type:
- Article
Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 6, p. 1042, doi. 10.1080/14397595.2018.1538003
- By:
- Publication type:
- Article
Intravesical Treatments of Bladder Cancer: Review.
- Published in:
- Pharmaceutical Research, 2008, v. 25, n. 7, p. 1500, doi. 10.1007/s11095-008-9566-7
- By:
- Publication type:
- Article